Hudock Inc’s Veracyte VCYT Stock Holding History

Hudock Inc’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$9K	–	825
2022 Q2	$9K	Hold	500	–	–	﹤0.01%	539
2022 Q1	$13K	Hold	500	–	–	﹤0.01%	514
2021 Q4	$20K	Hold	500	–	–	0.01%	444
2021 Q3	$23K	Hold	500	–	–	0.01%	437
2021 Q2	$19K	Hold	500	–	–	0.01%	459
2021 Q1	$26K	Hold	500	–	–	0.01%	409
2020 Q4	$24K	Hold	500	–	–	0.01%	404
2020 Q3	$16K	Hold	500	–	–	0.01%	411
2020 Q2	$12K	Hold	500	–	–	﹤0.01%	430
2020 Q1	$12K	Hold	500	–	–	﹤0.01%	386
2019 Q4	$13K	Hold	500	–	–	﹤0.01%	397
2019 Q3	$12K	Buy	+500	New	+$13.3K	﹤0.01%	406

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Hudock Inc's VCYT Position: Q3 2022 in Review

Hudock Inc sold out of Veracyte (VCYT) in Q3 2022, closing a stake of 500 shares — an estimated $9K sold.

Hudock Inc first reported a position in VCYT in Q3 2019 and held it in 12 quarters. The position peaked at $26K in Q1 2021. 208 funds tracked by Wall St. Rank hold VCYT as of Q3 2022.

Hudock Inc reported no remaining Veracyte position as of Q3 2022 after selling out during the quarter.
Hudock Inc sold 500 Veracyte shares in Q3 2022, an estimated $9K.
Hudock Inc first reported a position in Veracyte in Q3 2019 and held it in 12 quarters.
Hudock Inc's Veracyte position peaked at $26K in Q1 2021.
208 funds tracked by Wall St. Rank held Veracyte as of Q3 2022.

Based on Hudock Inc's 13F filing for Q3 2022, filed 2 Nov 2022.